文献速递技术与安全CT

低渗CT对比剂(碘海醇350)体外加温对外渗及患者反应率的影响:回顾性研究

Effect of Extrinsic Warming of Low-Osmolality CT Contrast Media (Iohexol 350) on Extravasations and Patient Reaction Rates: A Retrospective Study.
PubMed 文献 · AJR Am J Roentgenol · 2021-07-28

该回顾性研究比较了碘海醇350 mg I/mL加温至体温(37°C)与室温保存后注射的不良事件发生率。结果显示两组在总体不良反应、外渗、过敏及过敏样反应、生理反应率上均无显著差异,室温组不良事件率非劣于体温组,提示注射前加温对比剂的资源投入可能并不必要。

要点

  • 室温碘海醇350的总体不良反应率非劣于体温组,差异无统计学意义。
  • 外渗是最常见不良事件,两组外渗率无显著差异。
  • 过敏及过敏样反应率低,两组间差异无统计学意义。

核心结论

  • 维持碘海醇350在室温下注射,其不良反应发生率非劣于加温至体温后注射。

研究设计与样本

  • 回顾性研究,比较碘海醇350加温至体温(37°C)组(3939例)与室温组(3933例)的成人CT检查患者。
  • 参考标准为电子病历记录的不良事件,包括外渗、过敏及过敏样反应、生理反应。

诊断标准与关键数值

  • 体温组不良事件率0.28%(95% CI 0.14-0.50%),均为外渗;过敏及过敏样反应率0.00%(97.5% CI 0.00-0.09%)。
  • 室温组不良事件率0.43%(95% CI 0.25-0.69%);外渗率0.33%(95% CI 0.17-0.56%);过敏及过敏样反应率0.10%(95% CI 0.03-0.26%)。
  • 多因素回归显示室温组每100例患者超额不良事件0.27例,低于0.6%非劣效界值。

临床应用与阅片要点

  • 日常CT增强检查中可考虑室温使用碘海醇350,无需常规加温。
  • 仍需关注外渗风险,但室温组外渗率与加温组无显著差异。

局限性

  • 回顾性研究设计,可能存在选择偏倚和信息偏倚。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Extrinsic warming of iodinated CT contrast media to body temperature reduces viscosity and injection pressures. However, studies examining the effect of extrinsic warming on clinical adverse events are limited in number and provide conflicting results. Therefore, consensus practice recommendations have been sparse. OBJECTIVE. The purpose of this study is to compare rates of extravasation, allergic and allergiclike reactions, and physiologic reactions between iohexol 350 mg I/mL warmed to body temperature (37°C) versus this agent maintained at room temperature. METHODS. This retrospective study compared adult patients who received CT examinations using IV iohexol 350 that had either been warmed to body temperature or maintained at room temperature. At our institution, contrast media had historically been warmed to body temperature before a protocol change unrelated to this investigation. Information on the patient and CT examination was extracted from the electronic medical record. Adverse events, including extravasations, allergic and allergiclike reactions, and physiologic reactions, were compared between groups. RESULTS. A total of 3939 patients received contrast media warmed to body temperature before the protocol change; 3933 patients received contrast media at room temperature after the protocol change. The body temperature group experienced 11 (0.28%; 95% CI, 0.14-0.50%) adverse events, all extravasations; the allergic and allergic-like reaction rate was 0.00% (97.5% CI, 0.00-0.09%). The room temperature group experienced 17 (0.43%; 95% CI, 0.25-0.69%) adverse events: 13 (0.33%; 95% CI, 0.17-0.56%) extravasations and four (0.10%; 95% CI, 0.03-0.26%) allergic and allergiclike reactions. No physiologic reaction occurred in either group. The two groups were not different in terms of overall reaction rate (p = .19), extravasation rate (p = .69), allergic and allergiclike reaction rate (p = .06), or physiologic reaction rate (p > .99). Logistic regression adjusting for patient and CT characteristics (age, sex, conventional CT vs CTA, contrast media volume, injection location) showed no significant association of patient group and adverse reaction rate (odds ratio, 2.19; 95% CI, 0.68-7.00). Multivariable regression modeling showed an excess of 0.27 adverse events per 100 patients within the room temperature group, which is below a 0.6% noninferiority margin. CONCLUSION. The data suggest that maintaining iohexol 350 at room temperature is noninferior to warming the agent to body temperature before injection. CLINICAL IMPACT. The resources involved to prewarm iohexol 350 before injection may not be warranted.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Basharat NF, Ranganathan K, Kang PT, et al. Effect of Extrinsic Warming of Low-Osmolality CT Contrast Media (Iohexol 350) on Extravasations and Patient Reaction Rates: A Retrospective Study. AJR Am J Roentgenol. 2021. PMID: 34319163. doi:10.2214/AJR.21.26256

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。